Guidance for the treatment and prevention of obstetric-associated venous thromboembolism

Shannon M. Bates, Saskia Middeldorp, Marc Rodger, Andra H. James, Ian Greer

Research output: Contribution to journalArticle

117 Citations (Scopus)
156 Downloads (Pure)


Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention of obstetric-related VTE is complicated by the need to consider fetal, as well as maternal, wellbeing when making management decisions. Although absolute VTE rates in this population are low, obstetric-associated VTE is an important cause of maternal morbidity and mortality. This manuscript, initiated by the Anticoagulation Forum, provides practical clinical guidance on the prevention and treatment of obstetric-associated VTE based on existing guidelines and consensus expert opinion based on available literature where guidelines are lacking.
Original languageEnglish
Pages (from-to)92-128
JournalJournal of Thrombosis and Thrombolysis
Issue number1
Publication statusPublished - 16 Jan 2016


  • Anticoagulants
  • Deep vein thrombosis
  • Obstetric
  • Pregnancy
  • Prophylaxis
  • Pulmonary embolism
  • Venous thromboembolism

Fingerprint Dive into the research topics of 'Guidance for the treatment and prevention of obstetric-associated venous thromboembolism'. Together they form a unique fingerprint.

Cite this